↓ Skip to main content

New Psychoactive Substances

Overview of attention for book
New Psychoactive Substances
Springer International Publishing

Table of Contents

  1. Altmetric Badge
    Book Overview
  2. Altmetric Badge
    Chapter 83 Bioanalytical Methods for New Psychoactive Substances
  3. Altmetric Badge
    Chapter 102 Toxicokinetics of NPS: Update 2017
  4. Altmetric Badge
    Chapter 107 Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action
  5. Altmetric Badge
    Chapter 110 Fatal Poisonings Associated with New Psychoactive Substances
  6. Altmetric Badge
    Chapter 111 Wastewater Analysis for Community-Wide Drugs Use Assessment
  7. Altmetric Badge
    Chapter 113 Pharmacology of MDMA- and Amphetamine-Like New Psychoactive Substances
  8. Altmetric Badge
    Chapter 124 Phencyclidine-Based New Psychoactive Substances
  9. Altmetric Badge
    Chapter 127 Emergence, Diversity, and Control of New Psychoactive Substances: A Global Perspective
  10. Altmetric Badge
    Chapter 134 Epidemiology of NPS Based Confirmed Overdose Cases: The STRIDA Project
  11. Altmetric Badge
    Chapter 135 Patterns of Acute Toxicity Associated with New Psychoactive Substances
  12. Altmetric Badge
    Chapter 143 The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonists as New Psychoactive Substances: Origins
  13. Altmetric Badge
    Chapter 144 The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonist New Psychoactive Substances: Evolution
  14. Altmetric Badge
    Chapter 148 1,2-Diarylethylamine- and Ketamine-Based New Psychoactive Substances
  15. Altmetric Badge
    Chapter 149 Synthetic Opioids
  16. Altmetric Badge
    Chapter 154 Designer Benzodiazepines: Another Class of New Psychoactive Substances
  17. Altmetric Badge
    Chapter 160 Responding to New Psychoactive Substances in the European Union: Early Warning, Risk Assessment, and Control Measures
  18. Altmetric Badge
    Chapter 177 Self-Experiments with Psychoactive Substances: A Historical Perspective
  19. Altmetric Badge
    Chapter 178 Neuropharmacology of Synthetic Cathinones
Attention for Chapter 143: The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonists as New Psychoactive Substances: Origins
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (83rd percentile)
  • Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter
15 X users
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
28 Dimensions

Readers on

mendeley
81 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Chapter title
The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonists as New Psychoactive Substances: Origins
Chapter number 143
Book title
New Psychoactive Substances
Published in
Handbook of experimental pharmacology, July 2018
DOI 10.1007/164_2018_143
Pubmed ID
Book ISBNs
978-3-03-010560-0, 978-3-03-010561-7
Authors

Samuel D. Banister, Mark Connor, Banister, Samuel D., Connor, Mark

Abstract

Synthetic cannabinoid receptor agonists (SCRAs) have proliferated as new psychoactive substances (NPS) over the past decade. Relative to other classes of NPS, SCRAs are structurally heterogeneous; however, most SCRAs act as potent, high-efficacy agonists of cannabinoid type 1 and type 2 receptors (CB1 and CB2, respectively). Characterization of the pharmacology and toxicology of these substances is hindered by the dynamic nature of the SCRA marketplace. Beyond basic pharmacological profiling at CB1 and CB2 receptors, very little is known about the acute or chronic effects of SCRAs. Many of the effects of SCRAs are qualitatively similar to those of the Δ9-tetrahydrocannabinol (Δ9-THC) found in cannabis. However, unlike Δ9-THC, SCRAs are frequently associated with serious adverse effects, including cardiotoxicity, nephrotoxicity, and death. This chapter will provide an overview of the structure and function of the primary target for SCRAs, the CB1 receptor, and survey the structure-activity relationships of the historical SCRAs that served as templates for the earliest generations of NPS.

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 81 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 81 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 13 16%
Researcher 10 12%
Student > Bachelor 10 12%
Other 7 9%
Student > Master 7 9%
Other 8 10%
Unknown 26 32%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 17 21%
Chemistry 11 14%
Medicine and Dentistry 7 9%
Neuroscience 6 7%
Biochemistry, Genetics and Molecular Biology 4 5%
Other 7 9%
Unknown 29 36%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 June 2023.
All research outputs
#3,104,495
of 25,996,988 outputs
Outputs from Handbook of experimental pharmacology
#102
of 692 outputs
Outputs of similar age
#58,227
of 343,067 outputs
Outputs of similar age from Handbook of experimental pharmacology
#2
of 7 outputs
Altmetric has tracked 25,996,988 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 692 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.8. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 343,067 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 5 of them.